PERTRIAL - Perla® Preservation Solution

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

December 11, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions
Organ TransplantIschemic Reperfusion Injury
Interventions
DRUG

Perla® Cold Preservation solution

Perla® must be cooled to 2° to 6 °C prior to use. The cold Preservation Solution is used to flush the isolated organ immediately before removal from the donor and/or immediately after removal from the donor. The solution is then left in the organ vasculature during hypothermic storage and transportation.

Trial Locations (1)

15006

Centro Hospitalario Universitario A Coruña (CHUAC), A Coruña

Sponsors
All Listed Sponsors
collaborator

Complexo Hospitalario Universitario de A Coruña

OTHER

lead

Advanced Life Solutions

INDUSTRY

NCT05194306 - PERTRIAL - Perla® Preservation Solution | Biotech Hunter | Biotech Hunter